Using D-dimer to predict bleeding risk on ECMO
Part of Blood & lymphatic clinical trials.
This trial is for adults in the ICU who recently started ECMO (a heart-lung bypass machine). It tests whether a blood test called D-dimer can help predict bleeding risk, which might improve safety for people on ECMO.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently in the intensive care unit (ICU)
- You have been on a heart-lung bypass machine (ECMO) for less than 24 hours
- You are covered by a French health insurance plan
- You do not have a known bleeding disorder or abnormal blood vessels
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how doctors can monitor your blood flow and fluid needs while you are on VV-ECMO. It involves a simple maneuver where your legs are raised to see if your heart needs more fluid.
This trial studies whether people on a breathing machine called VV-ECMO can be managed without routine blood thinners, to reduce bleeding risk. It is meant for adults with severe lung failure (ARDS) and checks that it is safe for you to avoid anticoagulation.
This trial tests whether a medication called recombinant von Willebrand factor (vWF) can help control major bleeding in adults who are on life support with ECMO. If you are on ECMO and have a serious bleed, this treatment might help stop the bleeding.
This study is testing a new D-dimer blood test (AQT90 FLEX) to see how well it detects blood clots in people who have symptoms but a low to moderate risk. If you join, this test may help rule out dangerous clots more quickly.
This trial tests if bivalirudin is a safe and effective blood thinner for people on ECMO, a machine that helps your heart and lungs. You may be eligible if you need this therapy and have no past reactions to similar medicines.
This trial tests if stable emergency room patients can be safely monitored without immediate blood tests. It may help reduce waiting times and unnecessary procedures.
Hear when a new ECMO trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.